Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.25
+0.03002.46%
Post-market: 1.250.00000.00%16:05 EDT
Volume:104.60K
Turnover:128.14K
Market Cap:62.27M
PE:-1.12
High:1.33
Open:1.21
Low:1.19
Close:1.22
Loading ...

Analysts Offer Insights on Healthcare Companies: Akoya Biosciences (AKYA) and HCA Healthcare (HCA)

TIPRANKS
·
26 Jan

Top Premarket Decliners

MT Newswires Live
·
13 Jan

Canaccord Genuity Downgrades Akoya Biosciences to Hold From Buy, $3.50 Price Target

MT Newswires Live
·
13 Jan

QTRX-Akoya Acquisition: Cautious Hold Amid Strategic Synergy and Integration Uncertainties

TIPRANKS
·
11 Jan

Quanterix Announces Merger with Akoya Biosciences

TIPRANKS
·
11 Jan

Akoya Biosciences downgraded to Hold from Buy at Canaccord

TIPRANKS
·
11 Jan

Quanterix Down 15.2%

THOMSON REUTERS
·
10 Jan

Akoya Biosciences Shares Jump 17.3% After Quanterix to Acquire Co

THOMSON REUTERS
·
10 Jan

BRIEF-Akoya Biosciences Discloses Termination Fees for Deal With Quanterix

Reuters
·
10 Jan

Traders Digest Strong Jobs Growth as US Equity Futures Drop Pre-Bell

MT Newswires Live
·
10 Jan

Akoya Biosciences Inc - Quanterix to Pay $9 Million Termination Fee IF Merger Terminated-SEC Filing

THOMSON REUTERS
·
10 Jan

Top Premarket Gainers

MT Newswires Live
·
10 Jan

Quanterix Agrees to Acquire Akoya Biosciences in All-Stock Deal

MT Newswires Live
·
10 Jan

BUZZ-Akoya Biosciences gains on merger deal with Quanterix

Reuters
·
10 Jan

Akoya Biosciences Shares Extend Gains, Last up 51.2% Premarket

THOMSON REUTERS
·
10 Jan

Quanterix to acquire Akoya Biosciences in an all-stock transaction

TIPRANKS
·
10 Jan

BRIEF-Quanterix To Acquire Akoya Biosciences

Reuters
·
10 Jan

Quanterix to Buy Akoya Biosciences in All-Stock Deal

MT Newswires Live
·
10 Jan

Quanterix Corp - Shareholders to Own 70% of Combined Company

THOMSON REUTERS
·
10 Jan

Quanterix Corp - Expected $40 Million Annual Cost Synergies by End of 2026

THOMSON REUTERS
·
10 Jan